| Breakdown | TTM | Apr 2024 | Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.29B | 34.98B | 25.78B | 42.78B | 37.15B | 38.93B |
| Gross Profit | 13.70B | 13.26B | 7.93B | 14.19B | 13.11B | 13.16B |
| EBITDA | 2.90B | 3.86B | -964.00M | 3.77B | 3.96B | 2.92B |
| Net Income | 353.00M | 1.14B | -2.49B | 1.48B | 1.61B | 792.00M |
Balance Sheet | ||||||
| Total Assets | 41.19B | 42.40B | 43.22B | 47.54B | 43.26B | 41.38B |
| Cash, Cash Equivalents and Short-Term Investments | 4.90B | 6.03B | 5.61B | 7.38B | 5.75B | 4.92B |
| Total Debt | 11.02B | 10.34B | 8.46B | 11.81B | 8.77B | 7.00B |
| Total Liabilities | 19.83B | 20.36B | 21.97B | 24.30B | 20.89B | 18.20B |
| Stockholders Equity | 21.19B | 21.67B | 20.90B | 22.91B | 22.06B | 22.89B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.77B | -1.67B | -413.00M | 1.41B | 158.00M |
| Operating Cash Flow | 0.00 | 3.43B | -1.44B | 2.71B | 3.17B | 1.23B |
| Investing Cash Flow | 0.00 | -709.00M | -237.00M | -3.30B | -1.67B | -1.07B |
| Financing Cash Flow | 0.00 | -2.12B | 2.33B | 2.22B | -676.00M | 100.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥13.03B | 8.37 | ― | 4.36% | 41.95% | 35.36% | |
63 Neutral | ¥13.24B | 170.52 | ― | 3.44% | ― | ― | |
62 Neutral | ¥16.88B | 15.76 | ― | 3.75% | 19.17% | -42.56% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥119.42B | 13.82 | ― | 5.49% | -16.48% | -77.63% | |
52 Neutral | ¥12.03B | 13.48 | ― | 4.61% | -2.47% | 7.50% | |
51 Neutral | ¥7.94B | -14.29 | ― | 3.58% | 10.75% | 117.39% |